Verisome® Drug Delivery Technology

At the core of IBI’s product line is the unique and flexible Verisome® platform.  The Verisome® technology is a novel drug delivery system with very broad topical, systemic and ocular applications.  The ocular Verisome® products are uniquely positioned to treat ophthalmic diseases as they can be administered  by injection and slowly deliver the drug as the Verisome® system simultaneously degrades.  Delivery duration up to a year with a standard intravitreal injection has been demonstrated in human clinical trials.

The Verisome® drug delivery technology is the most advanced, yet simplest, system for controlling the release of therapeutic agents in the eye for extended periods of time.   The Verisome® technology’s versatility can support a wide range of products individually formulated to meet the requirements of a given active agent and the demands of a specific clinical situation.


My Canadian Pharmacy is an informative service. All the information should not be used in the purposes to establish a diagnosis and prescribe a treatment plan. Our company is a vendor, not a drug manufacturer. We cooperate with drug manufacturers who distribute their products to us. We have no relation with Icon Bioscience and Verisome. They move to another domain. We bear no responsibility for any damage brought to your health. All the questions related to the drug quality should be addressed to the drug manufacturer directly.